We serve Chemical Name:2-(4-Bromophenyl)-1-(2-hydroxy-4-methoxyphenyl)ethanone CAS:170014-23-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(4-Bromophenyl)-1-(2-hydroxy-4-methoxyphenyl)ethanone
CAS.NO:170014-23-0
Synonyms:2-(4-Bromophenyl)-1-(2-hydroxy-4-methoxyphenyl)ethanone
Molecular Formula:C15H13BrO3
Molecular Weight:321.16600
HS Code:2914700090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:46.53000
Exact Mass:320.00500
LogP:3.58870
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-(4-Bromophenyl)-1-(2-hydroxy-4-methoxyphenyl)ethanone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(4-Bromophenyl)-1-(2-hydroxy-4-methoxyphenyl)ethanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(4-Bromophenyl)-1-(2-hydroxy-4-methoxyphenyl)ethanone Use and application,2-(4-Bromophenyl)-1-(2-hydroxy-4-methoxyphenyl)ethanone technical grade,usp/ep/jp grade.
Related News: Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule. 2-(4-Bromophenyl)-1-(2-hydroxy-4-methoxyphenyl)ethanone manufacturer Patients given the vaccine also experienced a reduction in cerebrospinal fluid biomarkers of abnormal tau, results show. 2-(4-Bromophenyl)-1-(2-hydroxy-4-methoxyphenyl)ethanone supplier Beta Bionics is a for-profit Massachusetts public benefit corporation founded in 2015 to commercialize the iLet, a revolutionary bionic pancreas that is driven by mathematical dosing algorithms, which incorporate lifelong autonomous learning to automatically control glycemia. 2-(4-Bromophenyl)-1-(2-hydroxy-4-methoxyphenyl)ethanone vendor Factors that have a significant impact on the sales volume of APIs come from the production side, which mainly includes costs and processes. 2-(4-Bromophenyl)-1-(2-hydroxy-4-methoxyphenyl)ethanone factory Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule.
